Weekly Insulin Injection Option Launching in Canada June 30

A once-a-week insulin injection will be available in Canada starting this month, making the country the first in the world to launch the new adult diabetes medication. Insulin icodec, sold under the brand name Awiqli, will be available across the country beginning June 30, drug manufacturer Novo Nordisk announced this week. The product was approved by Health Canada in March for the treatment of adults with either Type 1 or Type 2 diabetes. “By transitioning from daily basal insulin injections to just one per week, Awiqli’s convenience ultimately provides the choice for potentially more patients living with diabetes in need of basal insulin to better manage their condition,” said Dr. Alexander Abitbol, an endocrinologist at LMC, a publicly-funded diabetes and endocrinology specialty clinic with locations in both southern Ontario and Calgary....